Bill creates Stem Cell Clinic Advisory Group
Sacramento - California is a longtime leader in biotechnology and stem cell research. Prop 71, approved by voters in 2004, created the California Institute for Regenerative Medicine (CIRM) and authorized $3 billion in funding for stem cell research. As a result, significant advancements in stem cell research and treatments have been realized. Unfortunately, not all stem cell clinics are adhering to the expected high standards of review within the industry and, as a result, patients have been subjected to unscrupulous, sometimes harmful practices. AB 617 will address those entities by creating a Stem Cell Clinic Regulation Advisory Group.
“California has been a leader in the research and development of stem cell therapies,” said Speaker pro Tem Kevin Mullin. “As a result of California’s leadership, doctors have used stem cells to treat patients with cancer and disorders of the blood and immune system and other conditions.”